title: Disappearance of bone marrow B cell clonal expansion in patients with type II hepatitis C virus-related cryoglobulinemic glomerulonephritis after clinical efficient rituximab therapy.
authors.forename: L
authors.initials: L
authors.lastname: Quartuccio
authors.forename: S
authors.initials: S
authors.lastname: Salvin
authors.forename: M
authors.initials: M
authors.lastname: Fabris
authors.forename: S
authors.initials: S
authors.lastname: Sacco
authors.forename: S
authors.initials: S
authors.lastname: De Vita
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001402:B-Lymphocytes / Q000187:drug effects*; D003449:Cryoglobulinemia / Q000276:immunology*; D005260:Female; D005921:Glomerulonephritis / Q000276:immunology*; D019698:Hepatitis C, Chronic / Q000150:complications*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008212:Lymphocyte Depletion / Q000379:methods; D008297:Male; D008875:Middle Aged; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab